Abstract
Context: Pembrolizumab (Keytruda; Merck Sharp & Dohme) is a humanized IgG4 monoclonal antibody used in cancer immunotherapy. It targets the progra......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
